Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit | R&D Systems HSFB00D product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

ELISA/assay

product name :

Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

catalog :

HSFB00D

quantity :

1 Kit (also 1 Pack (50 Plates), 1 Pack (6 Plates))

price :

695 USD

citations: 16

Reference
Ueno K, Kurazumi H, Suzuki R, Yanagihara M, Mizoguchi T, Harada T, et al. miR-709 exerts an angiogenic effect through a FGF2 upregulation induced by a GSK3B downregulation. Sci Rep. 2024;14:11372 pubmed publisher
Sikovanyecz J, Vincze M, Földesi I, Nemeth G, Kozinszky Z. Angiogenic factors measured in aspirated placental tissue between the 10 + 6 and 18 + 3 weeks of gestation. Reprod Biol. 2021;21:100572 pubmed publisher
Briasoulis E, Aravantinos G, Kouvatseas G, Pappas P, Biziota E, Sainis I, et al. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer. 2013;13:263 pubmed publisher
Llovet J, Peña C, Lathia C, Shan M, Meinhardt G, Bruix J. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012;18:2290-300 pubmed publisher
Schirmer S, van Royen N, Moerland P, Fledderus J, Henriques J, van der Schaaf R, et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol. 2009;53:2141-7 pubmed publisher
Kanter J, Khan S, Kelher M, Gore L, Silliman C. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res. 2008;14:3942-7 pubmed publisher
Weiner L, Han R, Scicchitano B, Li J, Hasegawa K, Grossi M, et al. Dedicated epithelial recipient cells determine pigmentation patterns. Cell. 2007;130:932-42 pubmed
Anagnostopoulos A, Eleftherakis Papaiakovou V, Kastritis E, Tsionos K, Bamias A, Meletis J, et al. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity. Br J Haematol. 2007;137:560-8 pubmed
Wedgwood S, Devol J, Grobe A, Benavidez E, Azakie A, Fineman J, et al. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res. 2007;61:32-6 pubmed
Schneider P, Vasse M, Corbiere C, Legrand E, Marie Cardine A, Boquet C, et al. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor. Leuk Res. 2007;31:629-38 pubmed
Kulke M, Bergsland E, Ryan D, Enzinger P, Lynch T, Zhu A, et al. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J Clin Oncol. 2006;24:3555-61 pubmed
Bourlev V, Larsson A, Olovsson M. Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis. Am J Obstet Gynecol. 2006;194:755-9 pubmed
Mross K, Drevs J, Müller M, Medinger M, Marme D, Hennig J, et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer. 2005;41:1291-9 pubmed
Lacoste E, Martineau I, Gagnon G. Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol. 2003;74:1498-507 pubmed
Huang S, Kim S, Lee A, Karashima T, Bucana C, Kedar D, et al. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel. Cancer Res. 2002;62:5720-6 pubmed
Esner M, Pachernik J, Hampl A, Dvorak P. Targeted disruption of fibroblast growth factor receptor-1 blocks maturation of visceral endoderm and cavitation in mouse embryoid bodies. Int J Dev Biol. 2002;46:817-25 pubmed

product information

master code :

HSFB00D

SKU :

HSFB00D

product name :

Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

unit size :

1 Kit (also 1 Pack (50 Plates), 1 Pack (6 Plates))

description :

The Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit from R&D Systems quantifies human FGF basic/FGF2/bFGF in serum (100 ul), edta plasma (100 ul), citrate plasma (100 ul), urine (100 ul).

target :

FGF basic/FGF2/bFGF

category :

ELISAs

species :

Human

specificity :

Natural and recombinant human FGF basic

gene symbol :

FGF2

assay length :

5.5 hours

elisaSampleTypes :

Serum (100 uL), EDTA Plasma (100 uL), Citrate Plasma (100 uL), Urine (100 uL)

elisaSensitivity :

0.07 pg/mL

elisaRange :

0.31 - 20 pg/mL

top caption :

Human FGF basic ELISA Standard Curve

applications :

ELISA

USD :

695 USD

product details :

The Quantikine HS Human FGF basic Immunoassay kit is a 5.5 hour solid phase ELISA designed to measure FGF basic levels in serum, plasma, and urine. It contains E. coli -expressed recombinant human FGF basic and antibodies raised against the recombinant factor. It has been shown to quantitate recombinant human FGF basic accurately. Results obtained using natural human FGF basic showed linear curves that were parallel to the standard curves obtained using the Quantikine HS kit standards. These results indicate that this kit can be used to determine relative mass values for natural human FGF basic.

alt names :

Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin

storage :

Store the unopened product at 2 - 8 ░C. Do not use past expiration date.